Analyzing cytokines as biomarkers to evaluate severity of glaucoma
Open Access
- 18 June 2017
- journal article
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 10 (6) , 925-930
Abstract
Inflammation and immune reaction have a strong link with the pathology of glaucoma especially AACG. Some cytokines may act as biomarkers to evaluate the severity of glaucoma. Anti-inflammatory treatments and controlling of IOP are necessary for the therapy of glaucoma.Keywords
This publication has 33 references indexed in Scilit:
- T-Helper1/T-Helper2 Cytokine Imbalance in the Iris of Patients with GlaucomaPLOS ONE, 2015
- Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patientsNephrology Dialysis Transplantation, 2013
- Multiplex Cytokine Analysis of Aqueous Humor in Eyes with Primary Open-Angle Glaucoma, Exfoliation Glaucoma, and CataractInvestigative Ophthalmology & Visual Science, 2012
- Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alphaIndian Journal Of Ophthalmology, 2012
- A Th1/Th2‐associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitizationClinical & Experimental Allergy, 2011
- Serum Cytokine Alteration is Associated With Optic Neuropathy in Human Primary Open Angle GlaucomaJournal of Glaucoma, 2010
- Sustained stress response after oxidative stress in trabecular meshwork cells2007
- Retinal-Cell–Conditioned Medium Prevents TNF-α-Induced Apoptosis of Purified Ganglion CellsInvestigative Ophthalmology & Visual Science, 2005
- Cytometric bead array: a multiplexed assay platform with applications in various areas of biologyClinical Immunology, 2004
- New definitions of glaucomaCurrent Opinion in Ophthalmology, 1997